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Abstract
Background. Atypical forms of pyoderma gangrenosum gener-
ally appear on the upper extremities; most frequently they
are associated with myeloproliferative disorders, including
osteomyelofibrosis. A response to systemic steroids is more
pronounced than in classical form. Sometimes it may be the
first sign of an underlying malignancy. Case report. We re-
ported a patient with atypical pyoderma gangrenosum developed
during the course of a myeloid malignancy – osteomyelofibrosis.
The lesions occurred after a minor trauma. Painful blistering
plaques, with an elevated, bluish-gray border were located
on the dorsal aspect of hands. No skin malignancy was
found. The lesions resolved rapidly to systemic steroids.
Conclusion. Considering the unusual clinical presentation
which makes the diagnosis difficult, as well as the fact that
atypical forms of pyoderma gangrenosum can be the first sign of
malignancies, especially myeloproliferative ones, recognizing
this entity enables timely guiding future investigations to-
ward their prompt detection.
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Apstrakt
Uvod. Atipične forme pyoderma gangrenosum obično se javljaju
na gornjim ekstremitetima. Najčešće su udružene sa mijelop-
roliferativnim oboljenjima uključujući i osteomijelofibrozu.
Odgovor na opštu kortikosteroidnu terapiju mnogo je brži
nego kod klasične forme. Ponekad mogu biti prvi znak pos-
tojećeg maligniteta. Prikaz bolesnika. Prikazali smo bolesni-
ka sa atipičnom formom pyoderma gangrenosum koja se razvila
tokom osnovne bolesti – osteomijelofibroze. Lezije na šaka-
ma javile su se nakon manje traume. Na dorzumu šaka nalazili
su se bolni plakovi sa bulama i uzdignutim, plavosivim, livid-
nim ivicama. Evaluacijom promena na koži nisu otkriveni
znaci kutanog maligniteta. Primenom opšte kortikosteroidne
terapije postignuta je brza klinička regresija kutanih lezija.
Zaključak. S obzirom na neuobičajenu kliničku sliku koja
otežava dijagnostiku, kao i činjenicu da atipične forme
pyoderma gangrenosum mogu biti prvi znak prisustva maligniteta,
naročito mijeloproliferativnih maligniteta, poznavanje ovog
entiteta omogućava pravovremeno usmeravanje daljih ispiti-
vanja u pravcu njihovog promptnog otkrivanja.
Ključne reči:
pioderma gangrenozum; mijeloproliferativni
poremećaji; dijagnoza; lečenje lekovima;
kortikosteroidni hormoni; lečenje, ishod.
Introduction
The diagnosis of pyoderma gangrenosum (PG) is
mostly based on the appearance of typical lesions – raised
plaques with progressive central necrosis and a bluish-red
necrotising border 
1, 2. Histopathological features are variable
and not specific; the presence of vasculitis is thought by
some authors to exclude the diagnosis 
1.
In 50% of the cases, PG is associated with bowel dis-
eases, although atypical forms are mostly reported with hae-
matologic diseases 
3, 4.
Diagnostic difficulties may arise in the absence of sys-
temic disease or with uncommon associations such as mye-
liod malignancies 
1, 2. Patients with myeloproliferative disor-
ders often have an atypical clinical presentation of PG, with
blisters, and relatively superficial involvement, obscuring the
correct clinical diagnosis 
1, 2, 5, 6.
Myelofibrosis with myeloid metaplasia (chronic myelo-
fibrosis,  osteomyelofibrosis) is a primary, Philadelphia
negative, myeloproliferative disorder arising from the level
of the haematopoetic stem cell. It is characterized with
hepato/splenomegaly, anemia and the tear drop erythrocytes
with leukoerythroblastic changes in typical cases. The hall-
mark is bone marrow fibrosis and myeloid metaplasia in the
spleen and liver 
1, 7. It is a rare disease of adults and the eld-
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years, insufficiency of hematopoesis and spleen enlargement
becomes the hallmark of the disease 
1, 7.
Skin changes in osteomyelofibrosis are infrequent.
Dermatitis resembling Sweet's syndrome or PG has already
been described 
1–3.
Case report
A 66-year-old Caucasian man was admitted to our In-
stitute in November 2006, with lesions on the dorsa al sides
of hands, which occurred about a month earlier, after a minor
trauma (working on the farm). Lesions enlarged symmetri-
cally and were accompanied by painful sensations.
Family history was unremarkable. In personal history
he had osteomyelofibrosis with myeloid metaplasia since
2003. The patient was treated with hydroxyurea (1–1.5 g
daily). Because of severe anemia and almost transfusion de-
pendence, the treatment with danazole started (400 mg daily)
in the beginning of September 2006. During the episodes of
severe anaemia, he also suffered from pneumonia.
A physical examination revealed dark erythematous
plaques, of 4 × 6 up to 8 × 10 cm in diameter, with a pro-
nounced, bluish-gray border, hemorrhagic blisters in the dor-
sal sides of both hands (Figures 1A, 1B), more pronounced
in the right one. Vesicles and pustules were noticed on the
surface of the lesions (Figure 1A). In the hospital, the lesions
enlarged quite rapidly, approximately 0.5 cm weekly, reach-
ing up to 12–14 cm in diameter.
No fever or other symptoms, except for lesional pain,
were found.
A histopathological examination of an incisional biopsy
of the lesion from the dorsal side of the left hand revealed a
dense mixed infiltrate in the papillary and reticular dermis,
consisting of lymphocytes, with no obvious malignant trans-
formation and neutrophils. The infiltrate is more pronounced
and dense in the reticular dermis, consisting mostly of lym-
phocytes with rare neutrophils. There were no signs of vas-
culitic lesions. In the epidermis some irregular acanthosis
and focal spongiosis were observed (Figure 2).
Immunohistochemical staining did not reveal any ma-
lignancy of the skin lesions (staining for CD34, CD3, c- kit,
CD79, CD 68 and myeloperoxidase (MPO) were negative).
Fig. 2 – Acanthosis and focal spongiosis in the epidermis;
dense mixed infiltrate in the dermis (H&E, 40 ×)
Immunological findings of antinuclear antibodies
(ANA), and antineutrophil cytoplasmic antibodies (ANCA)
were negative. Chest radiography was in physiological lim-
its. Protein electrophoresis was normal. There was a pro-
nounced leukocytosis, up to 34 × 10
9/l, with anemia – read
blood cell (RBC) count 2.74 × 10
12/l, hemoglobin (Hgb) 80
g/l and thrombocytopenia – platelet (Plt) 49 × 10 
9/l. The
sedimentation rate was increased – 80 mm in the first hour.
Routine biochemistry, including glucose level, total and
direct bilirubine, urea and creatinine, serum electrolytes,
liver enzymes was normal, except the raised level of lactate
dehydrogenase (LDH) (1 700 U/l) and low iron level (5.6
µmol/l).
Echosonography of the abdomen revealed an enlarge-
ment of the liver and spleen.
The patient was treated with oral prednisolone, 40
mg/day, and doxycycline, 200 mg/day. After only four days
of the initiating therapy, the lesions stopped to enlarge, the
inflammatory border was less pronounced. After a week of
the therapy the lesions started to regress. Oral prednisolone
was gradually tapered after two weeks of the treatment. A
month later, only hyperpigmented patches on the dorsal
hands were observed, no new lesions occurred (Figure 3).
The therapy was completely discontinued two months after
the initiation.
A. B.
Fig. 1 – A) right hand – dark erythematous plaque with vesicles and hemorrhagic blisters,
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Fig. 3 – Complete regression with hyperpigmented patches
Discussion
The uncommon association between myeloproliferative
disorders and PG is now well documented 
1–8. The lesions
are almost usually of an atypical appearance, with a bluish-
grey border instead of red violaceus border seen in classical
forms of PG and often accompanied by blisters 
1, 2.  The dis-
tribution of the lesions may be helpful in establishing a cor-
rect diagnosis 
3, 5. With classical PG, the predilection sites
are the legs, approximately in 78% of cases. On the contrary,
the lesions of atypical forms are frequently located in the up-
per extremities 
4, 6. Lesions often occur at the sites of minor
trauma 
4, as in our case, and are more superficial 
1–9.
Because of atypical appearance of PG, usually with
hemorrhagic blisters, pustules and crusting, especially in the
absence of systemic disease, or in the less obvious myelo-
proliferative disorders, a correct diagnosis  may be delayed
or missed in such patients 
1, 5, 10.
Once the diagnosis has been achieved, the response to
steroids is rapid, faster than in classical PG 
4. This rapid re-
sponse lends further supports to the diagnosis and is thought
by some authors to be an essential diagnostic criterion 
4, 5, 11.
The development of PG is possible in patients with
myeloid malignancy at any stage of the disease, even as the
presenting sign; the prognosis of these patients is particularly
poor 
1, 7.
Conclusion
Considering the unusual clinical presentation which
makes the diagnosis difficult, as well as the fact that atypical
forms of pyoderma gangrenosum can be the first sign of ma-
lignancies, especially myeloproliferative ones, recognizing
this entity enables timely guiding future investigations to-
ward their prompt detection.
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